The oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling, and therapeutic implications
Alfredo Iacoangeli, Allison A. Dilliott, Ahmad Al Khleifat, Peter M Andersen, Nazli A. Başak, View ORCID ProfileJohnathan Cooper-Knock, Philippe Corcia, Philippe Couratier, View ORCID ProfileMamede de Carvalho, Vivian Drory, Jonathan D. Glass, Marc Gotkine, Yossef Lerner, Orla Hardiman, John E. Landers, Russell McLaughlin, Jesús S. Mora Pardina, Karen E. Morrison, Susana Pinto, Monica Povedano, Christopher E. Shaw, Pamela J. Shaw, View ORCID ProfileVincenzo Silani, Nicola Ticozzi, View ORCID ProfilePhilip Van Damme, Leonard H. van den Berg, Patrick Vourc’h, Markus Weber, View ORCID ProfileJan H. Veldink, Project MinE ALS Sequencing Consortium, Richard JB Dobson, Guy A. Rouleau, Ammar Al Chalabi, View ORCID ProfileSali M.K. Farhan
doi: https://doi.org/10.1101/2024.03.21.24304693
Alfredo Iacoangeli
1Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
2Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
3Perron Institute for Neurological and Translational Science, University of Western Australia Medical School, Perth, Australia
Allison A. Dilliott
4Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
5Montreal Neurological Institute-Hospital, McGill University, Montreal, Quebec
Ahmad Al Khleifat
2Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
Peter M Andersen
6Department of Clinical Science, Umeå University, Umeå SE-901 85, Sweden
Nazli A. Başak
7Koc University, School of Medicine, Translational Medicine Research Center, NDAL, Istanbul, 34450, Turkey
Johnathan Cooper-Knock
8Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK
Philippe Corcia
9UMR 1253, Université de Tours, Inserm, Tours 37044, France
10Centre de référence sur la SLA, CHU de Tours, Tours 37044, France
Philippe Couratier
11Centre de référence sur la SLA, CHRU de Limoges, Limoges, France
12UMR 1094, Université de Limoges, Inserm, Limoges 87025, France
Mamede de Carvalho
13Instituto de Fisiologia, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon 1649-028, Portugal
Vivian Drory
14Department of Neurology, Tel-Aviv Sourasky Medical Centre, Tel-Aviv 64239, Israel
15Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel
Jonathan D. Glass
16Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, GA 30322, USA
Marc Gotkine
17Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91904, Israel
18Agnes Ginges Center for Human Neurogenetics, Department of Neurology, Hadassah Medical Center, Jerusalem 91120, Israel
Yossef Lerner
17Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91904, Israel
18Agnes Ginges Center for Human Neurogenetics, Department of Neurology, Hadassah Medical Center, Jerusalem 91120, Israel
Orla Hardiman
19Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin D02 PN40, Ireland
John E. Landers
20Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01655, USA
Russell McLaughlin
21Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Dublin D02 PN40, Ireland
Jesús S. Mora Pardina
22ALS Unit, Hospital Universitario San Rafael, Madrid, Spain
Karen E. Morrison
23School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast BT9 7BL, UK
Susana Pinto
13Instituto de Fisiologia, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon 1649-028, Portugal
Monica Povedano
24Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona 08907, Spain
Christopher E. Shaw
2Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
Pamela J. Shaw
8Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK
Vincenzo Silani
25Department of Neurology and Laboratory of Neuroscience, Istituto Auxologico Italiano, IRCCS, Milan 20149, Italy
26Department of Pathophysiology and Transplantation, “Dino Ferrari” Center, Università degli Studi di Milano, Milan 20122, Italy
Nicola Ticozzi
25Department of Neurology and Laboratory of Neuroscience, Istituto Auxologico Italiano, IRCCS, Milan 20149, Italy
26Department of Pathophysiology and Transplantation, “Dino Ferrari” Center, Università degli Studi di Milano, Milan 20122, Italy
Philip Van Damme
27Department of Neuroscience, Leuven Brain Institute (LBI), VIB, Center for Brain and Disease Research, University of Leuven (KU Leuven), Leuven, Belgium
28University Hospitals Leuven, Department of Neurology, Leuven 3000, Belgium
Leonard H. van den Berg
29Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht 3584 CX, Netherlands
Patrick Vourc’h
9UMR 1253, Université de Tours, Inserm, Tours 37044, France
30Service de Biochimie et Biologie molécularie, CHU de Tours, Tours 37044, France
Markus Weber
31Neuromuscular Diseases Unit/ALS Clinic, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland
Jan H. Veldink
29Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht 3584 CX, Netherlands
Richard JB Dobson
1Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
Guy A. Rouleau
4Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
5Montreal Neurological Institute-Hospital, McGill University, Montreal, Quebec
32Department of Genetics, McGill University, Montreal, Quebec
Ammar Al Chalabi
2Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
33National Institute for Health Research Biomedical Research Centre and Dementia Unit at South London and Maudsley NHS Foundation Trust and King’s College London, London, UK
34Department of Neurology, King’s College Hospital, London, UK
Sali M.K. Farhan
4Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
5Montreal Neurological Institute-Hospital, McGill University, Montreal, Quebec
32Department of Genetics, McGill University, Montreal, Quebec
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Posted March 26, 2024.
The oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling, and therapeutic implications
Alfredo Iacoangeli, Allison A. Dilliott, Ahmad Al Khleifat, Peter M Andersen, Nazli A. Başak, Johnathan Cooper-Knock, Philippe Corcia, Philippe Couratier, Mamede de Carvalho, Vivian Drory, Jonathan D. Glass, Marc Gotkine, Yossef Lerner, Orla Hardiman, John E. Landers, Russell McLaughlin, Jesús S. Mora Pardina, Karen E. Morrison, Susana Pinto, Monica Povedano, Christopher E. Shaw, Pamela J. Shaw, Vincenzo Silani, Nicola Ticozzi, Philip Van Damme, Leonard H. van den Berg, Patrick Vourc’h, Markus Weber, Jan H. Veldink, Project MinE ALS Sequencing Consortium, Richard JB Dobson, Guy A. Rouleau, Ammar Al Chalabi, Sali M.K. Farhan
medRxiv 2024.03.21.24304693; doi: https://doi.org/10.1101/2024.03.21.24304693
The oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling, and therapeutic implications
Alfredo Iacoangeli, Allison A. Dilliott, Ahmad Al Khleifat, Peter M Andersen, Nazli A. Başak, Johnathan Cooper-Knock, Philippe Corcia, Philippe Couratier, Mamede de Carvalho, Vivian Drory, Jonathan D. Glass, Marc Gotkine, Yossef Lerner, Orla Hardiman, John E. Landers, Russell McLaughlin, Jesús S. Mora Pardina, Karen E. Morrison, Susana Pinto, Monica Povedano, Christopher E. Shaw, Pamela J. Shaw, Vincenzo Silani, Nicola Ticozzi, Philip Van Damme, Leonard H. van den Berg, Patrick Vourc’h, Markus Weber, Jan H. Veldink, Project MinE ALS Sequencing Consortium, Richard JB Dobson, Guy A. Rouleau, Ammar Al Chalabi, Sali M.K. Farhan
medRxiv 2024.03.21.24304693; doi: https://doi.org/10.1101/2024.03.21.24304693
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2918)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12711)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4567)
- Geriatric Medicine (415)
- Health Economics (726)
- Health Informatics (2913)
- Health Policy (1068)
- Hematology (386)
- HIV/AIDS (922)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (467)
- Neurology (4335)
- Nursing (234)
- Nutrition (636)
- Oncology (2261)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (499)
- Pediatrics (1196)
- Primary Care Research (494)
- Public and Global Health (6916)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (436)
- Sports Medicine (383)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (178)